Galenika's privatisation is suspended in Serbia
This article was originally published in Scrip
Executive Summary
Serbia's national privatisation agency has announced that it is no longer selling its 70% stake in Galenika, the country's largest pharmaceutical manufacturer, and that no tenders will be organised this year. It said that no bidders could meet the requirements it had outlined.